LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant.

    Khaire, Niranjan Shiwaji / Kim, Dennis Dong Hwan / Law, Arjun D

    JAMA

    2023  Volume 330, Issue 2, Page(s) 190

    MeSH term(s) Adult ; Humans ; Base Sequence ; Hematopoietic Stem Cell Transplantation ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/therapy ; Neoplasm, Residual/diagnosis ; Neoplasm, Residual/genetics ; Sequence Analysis, DNA/methods
    Language English
    Publishing date 2023-05-08
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2958-0
    ISSN 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484
    ISSN (online) 1538-3598
    ISSN 0254-9077 ; 0002-9955 ; 0098-7484
    DOI 10.1001/jama.2023.8650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: "Likely to be missed if unsuspected":

    Sharma, Praveen / Khaire, Niranjan Shiwaji / Sreedharanunni, Sreejesh / Malhotra, Pankaj / Varma, Neelam

    Journal of cancer research and therapeutics

    2022  Volume 18, Issue 1, Page(s) 316–317

    MeSH term(s) Humans ; Imatinib Mesylate ; Oncogene Proteins, Fusion/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Receptor, Platelet-Derived Growth Factor alpha/genetics ; Receptor, Platelet-Derived Growth Factor alpha/metabolism ; mRNA Cleavage and Polyadenylation Factors/genetics
    Chemical Substances Oncogene Proteins, Fusion ; mRNA Cleavage and Polyadenylation Factors ; Imatinib Mesylate (8A1O1M485B) ; FIP1L1-PDGFRA fusion protein, human (EC 2.7.10.1) ; Receptor, Platelet-Derived Growth Factor alpha (EC 2.7.10.1)
    Language English
    Publishing date 2022-04-06
    Publishing country India
    Document type Case Reports ; Letter
    ZDB-ID 2187633-2
    ISSN 1998-4138 ; 0973-1482
    ISSN (online) 1998-4138
    ISSN 0973-1482
    DOI 10.4103/jcrt.JCRT_940_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Hemoglobin Andrew-Minneapolis-Bijnor HBB:c.[413T>C;435G>C] in a complex genotype with β-thalassemia trait: A diagnostic and management conundrum.

    Khaire, Niranjan Shiwaji / Jamwal, Manu / Sharma, Prashant / Hira, Jasbir Kaur / Chhabra, Sanjeev / Malhotra, Pankaj / Das, Reena

    International journal of laboratory hematology

    2022  Volume 44, Issue 4, Page(s) e164–e167

    MeSH term(s) Genotype ; Hemoglobins, Abnormal/genetics ; Humans ; Mutation ; beta-Globins/genetics ; beta-Thalassemia/diagnosis ; beta-Thalassemia/genetics ; beta-Thalassemia/therapy
    Chemical Substances Hemoglobins, Abnormal ; beta-Globins ; hemoglobin Andrew-Minneapolis (53986-72-4)
    Language English
    Publishing date 2022-03-09
    Publishing country England
    Document type Letter
    ZDB-ID 2268590-X
    ISSN 1751-553X ; 1751-5521 ; 0141-9854
    ISSN (online) 1751-553X
    ISSN 1751-5521 ; 0141-9854
    DOI 10.1111/ijlh.13821
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Authors' response.

    Soni, Shiv Lal / Kajal, Kamal / Yaddanapudi, L N / Malhotra, Pankaj / Puri, Goverdhan Dutt / Bhalla, Ashish / Singh, Mini P / Sehgal, Inderpaul Singh / Koushal, Vipin / Varma, Neelam / Biswal, Manisha / M Lakshmi, P V / Sharma, Sadhna / Suri, Vikas / Deepy, Z / Ram, Sant / Yadav, Jaivinder / Pandey, Navin / Sharma, Prashant /
    Malik, Nabhajit / Goyal, Kapil / Mehra, Aseem / Sahoo, Swapnajeet / Mohindra, Ritin / Francis, Jijo / Bhargava, Mudit / Singla, Karan / Babu, Preena / Verma, Amiy / Khaire, Niranjan Shiwaji / Guru, R R

    The Indian journal of medical research

    2023  Volume 156, Issue 4&5, Page(s) 691–692

    Language English
    Publishing date 2023-03-15
    Publishing country India
    Document type Letter ; Comment
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/0971-5916.371296
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Fibrodysplasia ossificans progressiva--primum non nocere.

    Muthu, Valliappan / Khaire, Niranjan Shiwaji / Varma, Subhash

    Clinical rheumatology

    2014  Volume 33, Issue 4, Page(s) 591–592

    MeSH term(s) Adolescent ; Deglutition Disorders/diagnostic imaging ; Deglutition Disorders/etiology ; Humans ; Kyphosis/diagnostic imaging ; Kyphosis/etiology ; Male ; Myositis Ossificans/complications ; Myositis Ossificans/diagnostic imaging ; Radiography ; Scoliosis/diagnostic imaging ; Scoliosis/etiology
    Language English
    Publishing date 2014-02-05
    Publishing country Germany
    Document type Case Reports ; Letter
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-014-2510-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Use of convalescent plasma for COVID-19 in India: A review & practical guidelines.

    Khaire, Niranjan Shiwaji / Jindal, Nishant / Yaddanapudi, Lakshmi Narayana / Sachdev, Suchet / Hans, Rekha / Sachdeva, Naresh / Singh, Mini P / Agarwal, Anup / Mukherjee, Aparna / Kumar, Gunjan / Sharma, Ratti Ram / Suri, Vikas / Puri, Goverdhan Dutt / Malhotra, Pankaj

    The Indian journal of medical research

    2021  Volume 153, Issue 1 & 2, Page(s) 64–85

    Abstract: Convalescent plasma (CP) therapy is one of the promising therapies being tried for COVID-19 patients. This passive immunity mode involves separating preformed antibodies against SARS-CoV-2 from a recently recovered COVID-19 patient and infusing it into a ...

    Abstract Convalescent plasma (CP) therapy is one of the promising therapies being tried for COVID-19 patients. This passive immunity mode involves separating preformed antibodies against SARS-CoV-2 from a recently recovered COVID-19 patient and infusing it into a patient with active disease or an exposed individual for prophylaxis. Its advantages include ease of production, rapid deployment, specificity against the target infectious agent, and scalability. In the current pandemic, it has been used on a large scale across the globe and also in India. However, unequivocal proof of efficacy and effectiveness in COVID-19 is still not available. Various CP therapy parameters such as donor selection, antibody quantification, timing of use, and dosing need to be considered before its use. The current review attempts to summarize the available evidence and provide recommendations for setting up CP protocols in clinical and research settings.
    MeSH term(s) Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19/therapy ; Humans ; Immunization, Passive ; India/epidemiology ; COVID-19 Serotherapy
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral
    Language English
    Publishing date 2021-04-04
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/ijmr.IJMR_3092_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Authors' response.

    Soni, Shiv Lal / Kajal, Kamal / Yaddanapudi, L N / Malhotra, Pankaj / Puri, Goverdhan Dutt / Bhalla, Ashish / Singh, Mini P / Sehgal, Inderpaul Singh / Koushal, Vipin / Varma, Neelam / Biswal, Manisha / M Lakshmi, P V / Sharma, Sadhna / Suri, Vikas / Deepy, Z / Ram, Sant / Yadav, Jaivinder / Pandey, Navin / Sharma, Prashant /
    Malik, Nabhajit / Goyal, Kapil / Mehra, Aseem / Sahoo, Swapnajeet / Mohindra, Ritin / Francis, Jijo / Bhargava, Mudit / Singla, Karan / Babu, Preena / Verma, Amiy / Khaire, Niranjan Shiwaji / Guru, R R

    The Indian journal of medical research

    2022  

    Language English
    Publishing date 2022-12-13
    Publishing country India
    Document type Journal Article
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/0971-5916.363264
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Use of convalescent plasma for COVID-19 in India

    Niranjan Shiwaji Khaire / Nishant Jindal / Lakshmi Narayana Yaddanapudi / Suchet Sachdev / Rekha Hans / Naresh Sachdeva / Mini P Singh / Anup Agarwal / Aparna Mukherjee / Gunjan Kumar / Ratti Ram Sharma / Vikas Suri / Goverdhan Dutt Puri / Pankaj Malhotra

    Indian Journal of Medical Research, Vol 153, Iss 1, Pp 64-

    A review & practical guidelines

    2021  Volume 85

    Abstract: Convalescent plasma (CP) therapy is one of the promising therapies being tried for COVID-19 patients. This passive immunity mode involves separating preformed antibodies against SARS-CoV-2 from a recently recovered COVID-19 patient and infusing it into a ...

    Abstract Convalescent plasma (CP) therapy is one of the promising therapies being tried for COVID-19 patients. This passive immunity mode involves separating preformed antibodies against SARS-CoV-2 from a recently recovered COVID-19 patient and infusing it into a patient with active disease or an exposed individual for prophylaxis. Its advantages include ease of production, rapid deployment, specificity against the target infectious agent, and scalability. In the current pandemic, it has been used on a large scale across the globe and also in India. However, unequivocal proof of efficacy and effectiveness in COVID-19 is still not available. Various CP therapy parameters such as donor selection, antibody quantification, timing of use, and dosing need to be considered before its use. The current review attempts to summarize the available evidence and provide recommendations for setting up CP protocols in clinical and research settings.
    Keywords antibody-dependent enhancement - anti-sars-cov-2 antibodies - convalescent plasma - covid-19 - donor selection - neutralizing antibodies - passive immunization ; Medicine ; R
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Wolters Kluwer Medknow Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.

    Soni, Shiv Lal / Kajal, Kamal / Yaddanapudi, L N / Malhotra, Pankaj / Puri, Goverdhan Dutt / Bhalla, Ashish / Singh, Mini P / Sehgal, Inderpaul Singh / Koushal, Vipin / Varma, Neelam / Biswal, Manisha / Lakshmi, P V M / Sharma, Sadhna / Suri, Vikas / Deepy, Z / Ram, Sant / Yadav, Jaivinder / Pandey, Navin / Sharma, Prashant /
    Malik, Nabhajit / Goyal, Kapil / Mehra, Aseem / Sahoo, Swapnajeet / Mohindra, Ritin / Francis, Jijo / Bhargava, Mudit / Singla, Karan / Babu, Preena / Verma, Amiy / Khaire, Niranjan Shiwaji / Guru, R R

    The Indian journal of medical research

    2021  Volume 153, Issue 1 & 2, Page(s) 115–125

    Abstract: Background & objectives: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. It is essential to analyze the epidemiological and clinical characteristics of patients with COVID-19 in ... ...

    Abstract Background & objectives: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. It is essential to analyze the epidemiological and clinical characteristics of patients with COVID-19 in different parts of our country. This study highlights clinical experience in managing patients with COVID-19 at a tertiary care centre in northern India.
    Methods: Clinical characteristics and outcomes of consecutive adults patients admitted to a tertiary care hospital at Chandigarh, India, from April 1 to May 25, 2020 were studied. The diagnosis of SARS-CoV-2 infection was confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) on throat and/or nasopharyngeal swabs. All patients were managed according to the institute's consensus protocol and in accordance with Indian Council of Medical Research guidelines.
    Results: During the study period, 114 patients with SARS-CoV-2 infection were admitted. The history of contact with COVID-19-affected individuals was available in 75 (65.8%) patients. The median age of the patients was 33.5 yr (13-79 yr), and there were 66 (58%) males. Of the total enrolled patients, 48 (42%) were symptomatic. The common presenting complaints were fever (37, 77%), cough (26, 54%) and shortness of breath (10, 20.8%). Nineteen (17%) patients had hypoxia (SpO
    Interpretation & conclusions: Majority of the patients with COVID-19 infection presenting to our hospital were young and asymptomatic. Fever was noted only in three-fourth of the patients and respiratory symptoms in half of them. Patients with comorbidities were more vulnerable to complications. Triaged classification of patients and protocol-based treatment resulted in good outcomes and low case fatality.
    MeSH term(s) Adolescent ; Adult ; Aged ; COVID-19/epidemiology ; Child ; Demography ; Female ; Humans ; India/epidemiology ; Male ; Middle Aged ; Pandemics ; Tertiary Care Centers/statistics & numerical data ; Young Adult
    Language English
    Publishing date 2021-09-01
    Publishing country India
    Document type Journal Article
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/ijmr.IJMR_2311_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India

    Shiv Lal Soni / Kamal Kajal / L N Yaddanapudi / Pankaj Malhotra / Goverdhan Dutt Puri / Ashish Bhalla / Mini P Singh / Inderpaul Singh Sehgal / Vipin Koushal / Neelam Varma / Manisha Biswal / P.V.M. Lakshmi / Sadhna Sharma / Vikas Suri / Z Deepy / Sant Ram / Jaivinder Yadav / Navin Pandey / Prashant Sharma /
    Nabhajit Malik / Kapil Goyal / Aseem Mehra / Swapnajeet Sahoo / Ritin Mohindra / Jijo Francis / Mudit Bhargava / Karan Singla / Preena Babu / Amiy Verma / Niranjan Shiwaji Khaire / R R Guru

    Indian Journal of Medical Research, Vol 153, Iss 1, Pp 115-

    2021  Volume 125

    Abstract: Background & objectives: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. It is essential to analyze the epidemiological and clinical characteristics of patients with COVID-19 in ... ...

    Abstract Background & objectives: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. It is essential to analyze the epidemiological and clinical characteristics of patients with COVID-19 in different parts of our country. This study highlights clinical experience in managing patients with COVID-19 at a tertiary care centre in northern India. Methods: Clinical characteristics and outcomes of consecutive adults patients admitted to a tertiary care hospital at Chandigarh, India, from April 1 to May 25, 2020 were studied. The diagnosis of SARS-CoV-2 infection was confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) on throat and/or nasopharyngeal swabs. All patients were managed according to the institute's consensus protocol and in accordance with Indian Council of Medical Research guidelines. Results: During the study period, 114 patients with SARS-CoV-2 infection were admitted. The history of contact with COVID-19-affected individuals was available in 75 (65.8%) patients. The median age of the patients was 33.5 yr (13-79 yr), and there were 66 (58%) males. Of the total enrolled patients, 48 (42%) were symptomatic. The common presenting complaints were fever (37, 77%), cough (26, 54%) and shortness of breath (10, 20.8%). Nineteen (17%) patients had hypoxia (SpO2<94%) at presentation and 36 (31%) had tachypnoea (RR >24). Thirty four (29.8%) patients had an accompanying comorbid illness. Age more than 60 yr and presence of diabetes and hypertension were significantly associated with severe COVID-19 disease. Admission to the intensive care unit (ICU) was needed in 18 patients (52%), with three (2.6%) patients requiring assisted ventilation. Mortality of 2.6 per cent (3 patients) was observed. Interpretation & conclusions: Majority of the patients with COVID-19 infection presenting to our hospital were young and asymptomatic. Fever was noted only in three-fourth of the patients and respiratory symptoms in half of them. ...
    Keywords acute respiratory distress syndrome - comorbidities - covid-19 - hypoxia - india - pandemic - pneumonia ; Medicine ; R
    Subject code 610 ; 616
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Wolters Kluwer Medknow Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top